Results 171 to 180 of about 45,136 (281)
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) is a common, persistent nasal disorder that poses significant public health challenges worldwide. Current treatment options frequently fail to achieve adequate symptom control in a substantial subset of patients. Over the past two decades, biologic therapies that target type 2 inflammatory pathways have been used to ...
Yuan Zhang +37 more
wiley +1 more source
Personalized Management of Chronic Rhinosinusitis in the Context of Immune Deficiency. [PDF]
Bell CM, Luong AU, Makary CA.
europepmc +1 more source
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama +16 more
wiley +1 more source
A murine sinonasal infection model recapitulates key features of clinical chronic rhinosinusitis. [PDF]
Vanderpool EJ, Rumbaugh KP.
europepmc +1 more source
The Future of ORLHNS and Associated Specialties Series: The future of rhinology, anterior skull base and facial plastic surgery [PDF]
Lund, VJ, Rowe-Jones, JM
core +1 more source
This meta‐analysis included 2292 patients with severe asthma who underwent biologic switching across 23 countries/regions. The most prevalent switching pattern was from mepolizumab to benralizumab, with suboptimal asthma control being the primary reason.
Yang Zheng +13 more
wiley +1 more source
Chronic Rhinosinusitis and Autoimmune Diseases: A Comprehensive Large Population-Based Analysis. [PDF]
Africa RE +3 more
europepmc +1 more source
Ray L. Friedman, Maurice Hockman
openaire +1 more source
Individual and Societal Economic Burden of Chronic Rhinosinusitis with or Without Nasal Polyps. [PDF]
Håkansson KEJ +6 more
europepmc +1 more source
This systematic review maps core outcome sets and harmonisation efforts in allergy and clinical immunology. Despite shared priorities such as quality of life and symptoms, substantial gaps and methodological inconsistencies remain, underscoring the need for broader coverage and standardised outcome measurement to improve comparability and clinical ...
Anastasia Demidova +45 more
wiley +1 more source

